Bjoern Chapuy

Bjoern Chapuy

UNVERIFIED PROFILE

Are you Bjoern Chapuy?   Register this Author

Register author
Bjoern Chapuy

Bjoern Chapuy

Publications by authors named "Bjoern Chapuy"

Are you Bjoern Chapuy?   Register this Author

53Publications

2366Reads

40Profile Views

LRRC33 is a novel binding and potential regulating protein of TGF-β1 function in human acute myeloid leukemia cells.

PLoS One 2019 10;14(10):e0213482. Epub 2019 Oct 10.

Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0213482PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6786621PMC
March 2020

Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.

Sci Rep 2019 Nov 15;9(1):16904. Epub 2019 Nov 15.

Division of Computational Biomedicine, Boston University School of Medicine, Boston, MA, 02118, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-019-52886-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858347PMC
November 2019

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome.

J Clin Oncol 2016 08 11;34(23):2690-7. Epub 2016 Apr 11.

Margaretha G.M. Roemer, Robert A. Redd, Heather Homer, Courtney F. Connelly, Gordon J. Freeman, Philippe Armand, Bjoern Chapuy, Donna S. Neuberg, and Margaret A. Shipp, Dana-Farber Cancer Institute; Azra H. Ligon, Heather H. Sun, and Scott J. Rodig, Brigham and Women's Hospital, Boston, MA; Margaretha G.M. Roemer and Daphne de Jong, VU University Medical Center, Amsterdam, the Netherlands; and Ranjana H. Advani, Yasodha Natkunam, Sarah E. Daadi, and Richard T. Hoppe, Stanford University Medical Center, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.4482DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019753PMC
August 2016

Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study.

J Clin Oncol 2016 08 6;34(23):2698-704. Epub 2016 Jun 6.

Alexander M. Lesokhin and Deepika Cattry, Memorial Sloan Kettering Cancer Center; Alexander M. Lesokhin, Weill Cornell Medical College, New York, NY; Stephen M. Ansell, Mayo Clinic, Rochester, MN; Philippe Armand, Bjoern Chapuy, Gordon J. Freeman, Scott J. Rodig, and Margaret A. Shipp, Dana-Farber Cancer Institute; David Avigan, Beth Israel Deaconess Medical Center; Azra H. Ligon and Scott J. Rodig, Brigham and Women's Hospital, Boston, MA; Emma C. Scott, Oregon Health & Science University Knight Cancer Institute, Portland, OR; Ahmad Halwani, University of Utah Huntsman Cancer Institute, Salt Lake City, UT; Martin Gutierrez, Hackensack University Medical Center, Hackensack; Lili Zhu, Joseph F. Grosso, and M. Brigid Bradley Garelik, Bristol-Myers Squibb, Princeton, NJ; Michael M. Millenson, Fox Chase Cancer Center; Adam D. Cohen and Stephen J. Schuster, University of Pennsylvania, Philadelphia, PA; Daniel Lebovic, University of Michigan, Ann Arbor, MI; Madhav Dhodapkar, Yale Cancer Center, New Haven, CT; Ivan Borrello, Johns Hopkins University School of Medicine, Baltimore, MD; and John Timmerman, University of California, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.9789DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019749PMC
August 2016

NLRC5/MHC class I transactivator is a target for immune evasion in cancer.

Proc Natl Acad Sci U S A 2016 May 9;113(21):5999-6004. Epub 2016 May 9.

Department of Microbial Pathogenesis and Immunology, Texas A&M Health Science Center, College Station, TX 77843;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1602069113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4889388PMC
May 2016

Resolving the daratumumab interference with blood compatibility testing.

Transfusion 2015 Jun 12;55(6 Pt 2):1545-54. Epub 2015 Mar 12.

Blood Bank, Department of Pathology, Brigham and Women's Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.13069DOI Listing
June 2015

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma.

N Engl J Med 2015 Jan 6;372(4):311-9. Epub 2014 Dec 6.

From the Mayo Clinic, Rochester, MN (S.M.A.); Memorial Sloan Kettering Cancer Center (A.M.L., D.C.) and Weill Cornell Medical College (A.M.L.) - both in New York; Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center, Baltimore (I.B.); University of Utah Huntsman Cancer Institute, Salt Lake City (A.H.); Oregon Health and Science University and the Knight Cancer Institute, Portland (E.C.S.); John Theurer Cancer Center, Hackensack University Medical Center, Hackensack (M.G.), and Bristol-Myers Squibb, Lawrenceville (L.Z., J.F.G., S.Y.K.) - both in New Jersey; Abramson Cancer Center, University of Pennsylvania (S.J.S.), and Fox Chase Cancer Center (M.M.M.) - both in Philadelphia; Dana-Farber Cancer Institute (G.J.F., B.C., M.A.S., P.A.) Brigham and Women's Hospital (S.J.R., A.H.L.), and Harvard Medical School (G.J.F., B.C., M.A.S., P.A., S.J.R., A.H.L.) - all in Boston; and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles (J.M.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1411087DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348009PMC
January 2015

MYC deregulation in lymphoid tumors: molecular mechanisms, clinical consequences and therapeutic implications.

Biochim Biophys Acta 2014 Dec 6;1846(2):457-67. Epub 2014 Sep 6.

Institute of Hematology and Transfusion Medicine, Department of Diagnostic Hematology, Indiry Gandhi Str. 14, 02-776 Warsaw, Poland. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0304419X140008
Publisher Site
http://dx.doi.org/10.1016/j.bbcan.2014.08.006DOI Listing
December 2014

Selective JAK2 inhibition specifically decreases Hodgkin lymphoma and mediastinal large B-cell lymphoma growth in vitro and in vivo.

Clin Cancer Res 2014 May 7;20(10):2674-83. Epub 2014 Mar 7.

Authors' Affiliations: Medical Oncology, Dana-Farber Cancer Institute; Section of Computational Biomedicine, Boston University School of Medicine; and Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-13-3007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084704PMC
May 2014

Intracellular ATP-binding cassette transporter A3 is expressed in lung cancer cells and modulates susceptibility to cisplatin and paclitaxel.

Oncology 2013 15;84(6):362-70. Epub 2013 May 15.

Department of Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany. tobias.overbeck @ med.uni-goettingen.de

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000348884DOI Listing
August 2013

FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas.

Nature 2012 Jan;481(7379):90-3

Department of Pathology, NYU Cancer Institute, New York University School of Medicine, New York, New York 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature10688DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344385PMC
January 2012

Yttrium 90 ibritumomab tiuxetan (Zevalin): a new bullet in the fight against malignant lymphoma?

Biotechnol J 2007 Nov;2(11):1435-43

Department of Hematology and Oncology, Georg August University, Göttingen, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/biot.200700043
Publisher Site
http://dx.doi.org/10.1002/biot.200700043DOI Listing
November 2007

CD45 monoclonal antibody-mediated cytolysis of human NK and T lymphoma cells.

Haematologica 2006 Jul;91(7):886-94

Department of Hematology and Oncology, Georg-August-Universität Goettingen, Goettingen, Germany.

View Article

Download full-text PDF

Source
July 2006